Kythera Biopharmaceuticals Inc. is slashing more than half its workforce, letting go 117 workers in the wake of its Oct. 1 acquisition by Dublin-based pharmaceutical company Allergan plc in an all-cash deal valued at roughly $2.1 billion.
Herbalife Ltd. shares dropped sharply Wednesday, dipping to $52.26 at one point for a decrease of 10.3 percent.
Two West L.A. pharmacy owners were arrested Thursday on federal drug trafficking and money laundering charges alleging they used a bogus pharmacy to divert narcotics to the black market.
A “Shark Tank” type pitch fest for marijuana businesses opened at the L.A. Hotel Downtown Tuesday, attracting a number of budding local entrepreneurs.
Democratic presidential candidate Hillary Clinton may have to shoulder the blame for the hit taken by local biotech stocks on Monday.
Amgen Inc. announced Wednesday that it will acquire Dezima Pharma B.V., a Netherlands-based biotech that develops blood disorder treatments.
The AIDS Healthcare Foundation on Monday filed more than a half million signatures needed for a ballot measure on mandatory condom usage in adult films throughout California.
Amgen Inc. faces a new type of competition with the launch of Zarxio, the first biosimilar drug approved for sale in the U.S.
Cedars-Sinai Health System announced Tuesday that it acquired the 145-bed Marina del Rey Hospital and a neighboring medical office building. The terms of the deal were not disclosed, but county records show the hospital property traded for $25.3 million in mid-August.
Medbox Inc. Founder P. Vincent Mehdizadeh is letting 13 million shares of his company go up in smoke, raising the value of those held by others.
Amgen Inc. has applied to the Food and Drug Administration for permission to sell etelcalcetide, a treatment for an ailment found in patients on dialysis, the company announced Tuesday.
Owners and employees of several Los Angeles-area businesses were convicted this week of operating Medicare fraud schemes that took in about $7 million in false billing.
Amgen Inc. has agreed to a $71 million settlement over claims that the pharmaceutical giant marketed two of its drugs for uses not approved by the Food and Drug Administration.
A month after being delisted from the Nasdaq Capital Market, diagnostic test maker Response Genetics Inc. announced Monday it declared Chapter 11 bankruptcy and would sell its assets to cancer diagnostics company Cancer Genetics Inc. for $14 million.
IPC Healthcare has agreed to be acquired by Team Health Holdings Inc. for $1.6 billion in cash, the companies announced Tuesday.